These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28154332)

  • 1. [A New Pain Regulatory System via the Brain Long Chain Fatty Acid Receptor GPR40/FFA1 Signal].
    Nakamoto K
    Yakugaku Zasshi; 2017; 137(2):199-204. PubMed ID: 28154332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic GPR40 signaling activated by free long chain fatty acids suppresses CFA-induced inflammatory chronic pain.
    Nakamoto K; Nishinaka T; Sato N; Mankura M; Koyama Y; Kasuya F; Tokuyama S
    PLoS One; 2013; 8(12):e81563. PubMed ID: 24349089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of brain n-3 fatty acids-GPR40/FFAR1 signaling in pain].
    Nakamoto K; Tokuyama S
    Nihon Yakurigaku Zasshi; 2018; 151(1):21-26. PubMed ID: 29321392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of prohormone convertase 2 protein expression via GPR40/FFA1 in the hypothalamus.
    Nakamoto K; Aizawa F; Nishinaka T; Tokuyama S
    Eur J Pharmacol; 2015 Sep; 762():459-63. PubMed ID: 26071852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antinociceptive effect of docosahexaenoic acid (DHA) through long fatty acid receptor G protein-coupled receptor 40 (GPR40)].
    Nakamoto K; Nishinaka T; Sato N; Mankura M; Koyama Y; Tokuyama S
    Yakugaku Zasshi; 2014; 134(3):397-403. PubMed ID: 24584021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10/β-endorphin pathway.
    Mao XF; Wu HY; Tang XQ; Ali U; Liu H; Wang YX
    J Neuroinflammation; 2019 Apr; 16(1):84. PubMed ID: 30981281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system.
    Nakamoto K; Nishinaka T; Matsumoto K; Kasuya F; Mankura M; Koyama Y; Tokuyama S
    Brain Res; 2012 Jan; 1432():74-83. PubMed ID: 22137657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elucidation of mechanisms underlying docosahexaenoic acid-induced antinociception].
    Nishinaka T; Matsumoto K; Nakamoto K; Anbo A; Mankura M; Koyama Y; Tokuyama S
    Yakugaku Zasshi; 2013; 133(5):493-9. PubMed ID: 23649389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation of supraspinal GPR40/FFA1 receptor signalling regulates the descending pain control system.
    Nakamoto K; Nishinaka T; Sato N; Aizawa F; Yamashita T; Mankura M; Koyama Y; Kasuya F; Tokuyama S
    Br J Pharmacol; 2015 Mar; 172(5):1250-62. PubMed ID: 25362997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of GPR40, a long-chain free fatty acid receptor, in the production of central post-stroke pain after global cerebral ischemia.
    Harada S; Haruna Y; Aizawa F; Matsuura W; Nakamoto K; Yamashita T; Kasuya F; Tokuyama S
    Eur J Pharmacol; 2014 Dec; 744():115-23. PubMed ID: 25281202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A long chain fatty acid receptor GPR40 as a novel pain control system].
    Nakamoto K; Tokuyama S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):233-7. PubMed ID: 23012892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting FFA1 and FFA4 receptors in cancer-induced cachexia.
    Freitas RDS; Muradás TC; Dagnino APA; Rost FL; Costa KM; Venturin GT; Greggio S; da Costa JC; Campos MM
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E877-E892. PubMed ID: 32893672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligands at Free Fatty Acid Receptor 1 (GPR40).
    Hara T
    Handb Exp Pharmacol; 2017; 236():1-16. PubMed ID: 27757762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunctional GPR40/FFAR1 signaling exacerbates pain behavior in mice.
    Nakamoto K; Aizawa F; Miyagi K; Yamashita T; Mankura M; Koyama Y; Kasuya F; Hirasawa A; Kurihara T; Miyata A; Tokuyama S
    PLoS One; 2017; 12(7):e0180610. PubMed ID: 28723961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of inflammatory and neuropathic pain behaviors in mice through activation of free fatty acid receptor GPR40.
    Karki P; Kurihara T; Nakamachi T; Watanabe J; Asada T; Oyoshi T; Shioda S; Yoshimura M; Arita K; Miyata A
    Mol Pain; 2015 Feb; 11():6. PubMed ID: 25889021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linoleic acid activates GPR40/FFA1 and phospholipase C to increase [Ca2+]i release and insulin secretion in islet beta-cells.
    Zhou YJ; Song YL; Zhou H; Li Y
    Chin Med Sci J; 2012 Mar; 27(1):18-23. PubMed ID: 22734209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of polyunsaturated fatty acids and GPR40 receptor in brain.
    Khan MZ; He L
    Neuropharmacology; 2017 Feb; 113(Pt B):639-651. PubMed ID: 26005184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases.
    Christiansen E; Watterson KR; Stocker CJ; Sokol E; Jenkins L; Simon K; Grundmann M; Petersen RK; Wargent ET; Hudson BD; Kostenis E; Ejsing CS; Cawthorne MA; Milligan G; Ulven T
    Br J Nutr; 2015 Jun; 113(11):1677-88. PubMed ID: 25916176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor.
    Lin DC; Guo Q; Luo J; Zhang J; Nguyen K; Chen M; Tran T; Dransfield PJ; Brown SP; Houze J; Vimolratana M; Jiao XY; Wang Y; Birdsall NJ; Swaminath G
    Mol Pharmacol; 2012 Nov; 82(5):843-59. PubMed ID: 22859723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?
    Mancini AD; Poitout V
    Trends Endocrinol Metab; 2013 Aug; 24(8):398-407. PubMed ID: 23631851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.